https://www.selleckchem.com/pr....oducts/s-glutamic-ac
001), which was significantly associated with the presence of insulin resistance (OR=3, 95% CI 1.58 to 5.73; p0.001). This group presented lower levels of plasmatic adiponectin than controls, especially in those patients with EAT ≥4.5 mm (p=0.005) who also presented with heart failure more frequently (p=0.01). In patients with CCD, a higher EAT thickness is observed and is associated with an increased metabolic risk profile indicated mainly by insulin resistance. In patients with CCD, a higher EAT thickness is observed and i
Curtir
Comentario
Compartilhar
